Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Liver morbidity · patients with primary biliary cirrhosis.

It is very uncertain whether bezafibrate changes liver morbidity compared with no intervention (very low certainty).

1 finding from 1 review

Bezafibrate for primary biliary cirrhosis 2012 · Cochrane Headline outcomes only
RD 0
3 studies · 60 participants
Very low

Liver morbidity · patients with primary biliary cirrhosis.

It is very uncertain whether bezafibrate changes liver morbidity compared with ursodeoxycholic acid (very low certainty).

1 finding from 1 review

Bezafibrate for primary biliary cirrhosis 2012 · Cochrane Headline outcomes only
RD 0
2 studies · 69 participants
Very low